Structures by: Sukhonosova E. V.
Total: 7
Ethyl {2-[4-(4-isopropylphenyl)thiazol-2-yl]phenyl}carbamate
C21H22N2O2S
Acta Crystallographica Section E (2016) 72, 9 1321-1325
a=5.4534(11)Å b=17.203(3)Å c=20.060(4)Å
α=90° β=90° γ=90°
Ethyl {2-[4-(3-nitrophenyl)thiazol-2-yl]phenyl}carbamate
C18H15N3O4S
Acta Crystallographica Section E (2016) 72, 9 1321-1325
a=23.840(5)Å b=9.7401(19)Å c=7.1403(14)Å
α=90° β=90° γ=90°
2-Phenyl-5,6,7,8-tetrahydroimidazo[2,1-<i>b</i>][1,3]benzothiazole
C15H14N2S
Acta Crystallographica Section E (2014) 70, 6 o668
a=12.523(3)Å b=10.699(3)Å c=18.930(5)Å
α=90.00° β=102.291(6)° γ=90.00°
6-(4-Chlorophenyl)-3-methylimidazo[2,1-<i>b</i>]thiazole
C12H9ClN2S
Acta Crystallographica Section E (2013) 69, 11 o1701
a=7.0624(5)Å b=7.7132(5)Å c=10.3460(7)Å
α=93.3530(10)° β=90.1070(10)° γ=98.8320(10)°
7-Nitro-2-phenylimidazo[2,1-<i>b</i>][1,3]benzothiazole
C15H9N3O2S
Acta Crystallographica Section E (2014) 70, 2 o143-o144
a=6.8068(3)Å b=21.0244(9)Å c=9.0699(4)Å
α=90.00° β=105.0770(10)° γ=90.00°
3-Bromo-7-methoxy-2-phenylimidazo[2,1-<i>b</i>][1,3]benzothiazole
C16H11BrN2OS
Acta Crystallographica Section E (2013) 69, 4 o531
a=3.8346(4)Å b=9.4848(11)Å c=37.236(4)Å
α=90.00° β=91.810(2)° γ=90.00°
3-Bromo-2-[4-(methylsulfanyl)phenyl]-5,6,7,8-tetrahydro-1,3-benzothiazolo[3,2-<i>a</i>]imidazole
C16H15BrN2S2
Acta Crystallographica Section E (2014) 70, 5 o596-o597
a=7.3132(3)Å b=7.5663(3)Å c=14.4543(7)Å
α=95.0330(10)° β=97.1880(10)° γ=101.9380(10)°